82 filings
Page 2 of 5
8-K
fd6t uis8
27 Sep 22
Other Events
9:28am
8-K
1jwo6sjnl9dg5un
26 Sep 22
Report of Independent Registered Public Accounting Firm
5:27pm
8-K
gteklzc6ky80xg0
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
t6ky2 r20hebker066j
15 Aug 22
Equillium Reports Second Quarter 2022 Financial Results and Provides Clinical Development Updates
4:22pm
8-K
3ng5za2xfug 27r2
25 May 22
Submission of Matters to a Vote of Security Holders
4:57pm
8-K
p45xjvmn5xt ks2ttz
12 May 22
Equillium Reports First Quarter 2022 Financial Results and Provides Corporate and Clinical Development Updates
4:07pm
8-K
31ovvjtdgsxu9zo 7vdp
9 May 22
Other Events
8:06am
8-K/A
aqgwqa8kbi e9mhj1x7w
2 May 22
Financial Statements and Exhibits
1:19pm
8-K
2lbx19k0
25 Apr 22
Other Events
8:05am
8-K
s0chxazz1a6yihxqq6uz
23 Mar 22
Equillium Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate & Clinical Development Updates
4:05pm
8-K
nve8hvkcldix2r
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
nfot4ceywb30e0li
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
nii88l8szglsud5i5za
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
8-K
a23jhl55 e1la3nxrza7
10 Nov 21
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
4:05pm
8-K
rabwqrti3ipox9b x6v
10 Aug 21
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
4:11pm
8-K
7rs3uc ka
12 Jul 21
Regulation FD Disclosure
4:00pm
8-K
eyo4l8rq
14 Jun 21
Other Events
3:57pm
8-K
zewwhjecyj w9gz
11 Jun 21
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
7:00am
8-K
m5x0mhr997s
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
lx0dzo8x m08z5
7 Jun 21
Regulation FD Disclosure
3:13pm